Skip to Content

Join the 'Pancreatitis' group to help and get support from people like you.

Pancreatitis News

New Test May Help Spot Pancreatic Cancer Early

Posted 12 Jul 2017 by Drugs.com

WEDNESDAY, July 12, 2017 – A new, low-cost blood test may be an effective way to detect pancreatic cancer early, a research team says. The nation's No. 4 cancer killer, pancreatic cancer often goes undiagnosed until it is too far along to remove. Current screening techniques typically catch it only "after it causes pronounced symptoms, when it has advanced far enough to be lethal," said study ...

For Inflamed Pancreas, Eating Right Away May Be Best Medicine

Posted 16 May 2017 by Drugs.com

TUESDAY, May 16, 2017 – Getting hospital patients with mild pancreatitis to start eating sooner may speed their recovery, a new study says. The finding challenges the long-held belief that these patients should avoid solid food for days. The University of Michigan researchers analyzed studies that included nearly 1,000 people hospitalized for pancreatitis. This is when the pancreas becomes ...

Is Surgery Always Necessary for Gallstones?

Posted 7 Apr 2017 by Drugs.com

FRIDAY, April 7, 2017 – Gallbladder removal may not always necessary for gallstone pancreatitis, a new study suggests. Gallstone pancreatitis occurs when one or more gallstones gets stuck in a duct in the pancreas. This blocks pancreatic enzymes from leaving the pancreas and traveling to the small intestine to aid in digestion. When those enzymes back up into the pancreas, it causes inflammation ...

FDA Medwatch Alert: Viberzi (eluxadoline): Drug Safety Communication - Increased Risk of Serious Pancreatitis In Patients Without A Gallbladder

Posted 15 Mar 2017 by Drugs.com

ISSUE: FDA is warning that Viberzi (eluxadoline), a medicine used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. An FDA review found these patients have an increased risk of developing serious pancreatitis that could result in hospitalization or death. Pancreatitis may be caused by spasm of a certain digestive system muscle ...

FDA Issues Warning About Balloon Obesity Treatments

Posted 13 Feb 2017 by Drugs.com

MONDAY, Feb. 13, 2017 – Fluid-filled balloons placed in the stomach to treat obesity have been linked to serious complications, the U.S. Food and Drug Administration reports. The balloons treat obesity by taking up space in a patient's stomach, and are used in conjunction with diet and exercise. Two types of fluid-filled balloon systems – the ReShape Integrated Dual Balloon System and the ...

Losing Pancreas Fat May Treat Type 2 Diabetes

Posted 25 Dec 2015 by Drugs.com

THURSDAY, Dec. 24, 2015 – British researchers say that losing 1 gram of fat from the pancreas can reverse type 2 diabetes. The catch? No one has yet figured out how to lose weight just from the pancreas. And, this small study's findings suggest that to lose that much fat from the pancreas, someone with type 2 diabetes would need to have weight-loss surgery, or diet long enough to lose about 15 ...

Urine Test Might Find Pancreatic Cancer Early, Study Suggests

Posted 3 Aug 2015 by Drugs.com

MONDAY, Aug. 3, 2015 – Scientists report that they have developed a urine test that may detect pancreatic cancer at an early stage. Usually, symptoms of this deadly disease do not appear until it is at an advanced stage and has spread, and little can be done to save the patient. Researchers have been looking for a way to screen people for pancreatic cancer in the hopes that early detection might ...

Study Sees No Evidence Linking Diabetes Drugs With Pancreatic Cancer

Posted 26 Feb 2014 by Drugs.com

WEDNESDAY, Feb. 26, 2014 – There's no firm evidence that the type 2 diabetes medications known as incretin-based drugs cause pancreatitis or pancreatic cancer, U.S. and European health officials say. But it's too early to say there's definitely no link between the injectable drugs and pancreatitis or pancreatic cancer, according to the safety assessment by the U.S. Food and Drug Administration ...

Abbott Receives FDA Approval for Creon to Include Dosing Information for Patients With Chronic Pancreatitis and Pancreatectomy

Posted 5 May 2010 by Drugs.com

ABBOTT PARK, Ill.., May 3 /PRNewswire-FirstCall/ – Abbott (NYSE:ABT) today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for CREON® (pancrelipase) Delayed-Release Capsules that now includes dosing guidance in the prescribing information specific to patients with limited production of enzymes in the pancreas (exocrine pancreatic ...

Ask a Question

Further Information

Related Condition Support Groups

Chronic Pancreatitis, Gastrointestinal Disorders

Related Drug Support Groups

pancreatin, Pancreatin 4X, Hi-Vegi-Lip, albumin human, Plasbumin-20, Albumin-ZLB, Albuked 25, Kedbumin, Albuked, view more... Albuked 5, Albuminar-20, Flexbumin, Human Albumin Grifols, Albumin-Alpine, Alburx, Albuminar-25, Albunex, Plasbumin-25, Albumarc, Plasbumin-5, Buminate, Albuminar-5, Digipepsin, Donnazyme, Pan-2400, Plasbumin, Albutein, Albuminex